DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Cavalli G, Luca GD, Campochiaro C. et al.
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study.
Lancet Rheumatol 2020;
2: e325-e331
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.